4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001104659-25-062092
10% owner acquired 1,700 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC 10% owner | 2025-06-20 | Option exercise | −100 | $60.00 | $6,000 | 4,392,637 | I |
| ADAR1 Capital Management, LLC 10% owner | 2025-06-20 | Option exercise | −1,400 | $70.00 | $98,000 | 4,391,237 | I |
| ADAR1 Capital Management, LLC 10% owner | 2025-06-20 | Option exercise | −200 | $70.00 | $14,000 | 743,358 | I |
| Derivatives | |||||||
| ADAR1 Capital Management, LLC 10% owner | 2025-06-20 | Option exercise · Put Option (right to sell) | −1 | 0 | I | ||
| ADAR1 Capital Management, LLC 10% owner | 2025-06-20 | Option exercise · Put Option (right to sell) | −14 | 0 | I | ||
| ADAR1 Capital Management, LLC 10% owner | 2025-06-20 | Option exercise · Put Option (right to sell) | −2 | 0 | I | ||
Loading xslF345X05/tm2518715-1_4seq1.xml…